MARKET

ONCO

ONCO

Onconetix
NASDAQ
1.490
-0.020
-1.32%
Opening 09:53 02/11 EST
OPEN
1.460
PREV CLOSE
1.510
HIGH
1.490
LOW
1.420
VOLUME
14.47K
TURNOVER
--
52 WEEK HIGH
54.39
52 WEEK LOW
1.151
MARKET CAP
2.32M
P/E (TTM)
-0.0042
1D
5D
1M
3M
1Y
5Y
1D
Onconetix Shareholders Approve Flexible Reverse Stock Split Plan
TipRanks · 1d ago
Onconetix Inc. Held Special Shareholder Meeting
Reuters · 1d ago
Onconetix Inc. hielt Sonderversammlung ab
Reuters · 1d ago
Weekly Report: what happened at ONCO last week (0202-0206)?
Weekly Report · 2d ago
Weekly Report: what happened at ONCO last week (0126-0130)?
Weekly Report · 02/02 10:15
Weekly Report: what happened at ONCO last week (0119-0123)?
Weekly Report · 01/26 10:15
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 01/19 12:05
Weekly Report: what happened at ONCO last week (0112-0116)?
Weekly Report · 01/19 10:21
More
About ONCO
Onconetix, Inc. is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men’s health and oncology. The Company owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.

Webull offers Onconetix Inc stock information, including NASDAQ: ONCO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONCO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ONCO stock methods without spending real money on the virtual paper trading platform.